SUMMARY
The search for the ideal postoperative analgesic technique still continues. After caesarean section many options have been tried. These include intermittent opioid injections, continuous opioid infusions, patient controlled intravenous (IV) opiates, epidural infusions, single-shot epidural morphine, intrathecal morphine and nonsteroidal anti-inflammatory drugs [1] [2] [3] [4] [5] . Due to variable analgesia or unacceptable sideeffects, each technique is problematic in some patients. Recently, epidural pethidine has been suggested to have theoretical benefits over epidural morphine 4, 6 . Pethidine has intermediate lipophilicity compared with other opioids and has intrinsic local anaesthetic properties 4, [7] [8] [9] . The local anaesthetic effects of pethidine are, however, not significant in the doses used clinically 7, 10 . Lipophilicity does produce differing clinical profiles with the various epidural opioids 10 . Fentanyl is highly lipophilic, producing rapid onset of action, minimal rostral spread, short duration of action and dosing requirements similar to its IV requirements when given epidurally 11 .
Morphine, with its low lipophilicity, produces slow onset of action, significant rostral spread, long duration of action, and dosing requirements much lower than its IV requirements when given epidurally. In contrast, the intermediate lipophilicity of pethidine results in rapid onset of action, little rostral spread, intermediate duration of action and lower epidural dose requirements than with IV administration. The lack of rostral spread means pethidine, unlike morphine, is not associated with delayed respiratory depression. Pethidine should therefore be a good candidate for patient-controlled epidural analgesia (PCEA) 10 . This study set out to answer the question: Is PCEA pethidine better for post-caesarean analgesia than the commonly used single-dose of epidural morphine? The primary consideration was the quality of analgesia. The common opioid associated side-effects of nausea, vomiting and itch were also compared 12, 13 .
MATERIALS AND METHODS
Ethics approval was obtained from the Hospital Ethics Committee. Patients for caesarean section enrolled in the study after providing informed written consent. Patients on tranquilizers or with a history of substance abuse or allergy to either pethidine or morphine were excluded. Randomization to either the pethidine group (Group P) or morphine group (Group M) was undertaken by the pharmacy department using a computer random number program.
PCEA PETHIDINE VERSUS EPIDURAL MORPHINE AFTER CAESAREAN
The syringes in both groups were prepared by the pharmacy, looked identical and could only be decoded by taking the kit number to pharmacy. Breaking of codes was not required throughout the entire trial. Staff involved in the selection, care and evaluation of the patients were not aware of group allocation.
All patients received either a combined spinalepidural (intrathecal 0.5% heavy bupivacaine and intrathecal fentanyl 15 µg) or epidural only technique (2% lignocaine with adrenaline and fentanyl 50 to 100 µg). Eleven patients had caesarean sections for failure to progress and therefore had epidural catheters in situ from labour ward (seven from Group P and four from Group M). Group P received epidural pethidine 50 mg in 10 ml normal saline when the umbilical cord was cut. Subsequently pethidine 125 mg was diluted to a volume of 50 ml (0.25% solution) and connected to a PCA machine (Graseby) which delivered boluses epidurally. The machine was set to deliver 15 mg (6 ml) boluses on demand with a 10 minute lockout period. Group M received 4 mg of preservative-free morphine diluted to 10 ml with normal saline epidurally once the cord was cut. A 50 ml syringe of normal saline was then connected to a PCA machine (Graseby) and programmed to deliver a 6 ml bolus with a 10 minute lockout. Spare syringes, pre-prepared by pharmacy, were changed by the nursing staff on the ward.
Patients in both groups received oral paracetamol 1 g qid. Rescue analgesia was provided by intramuscular (IM) pethidine 100 mg 3 hrly prn. Patients with itch were treated with promethazine 10 to 25 mg orally or IM bd prn, and patients with nausea or vomiting were given metoclopramide 10 mg IV/IM tds prn.
The nursing staff were trained by the acute pain service in the use of a 100 mm visual analog pain scale and recorded pain scores at rest (0=no pain and 10= worst pain imaginable) at 2, 6, 8 and 24 hours postoperatively. A 100 mm visual analog scale was similarly used for nausea or vomiting (0=no nausea and 10=worst vomiting imaginable) and itch (0=no itch and 10=worst itch imaginable). The nausea/vomiting and itch scores were collected at similar intervals.
Pain, nausea and itch visual analog scores were continuously scaled variables. As the frequency distributions of pain, nausea and itch were not normally distributed (Kolmogorov-Smirnov tests for normality P<0.001 for all data collected), non-parametric testing was considered appropriate. Wilcoxon rank sum tests were performed for pain, nausea and itch at each of the four time points. The SPSS statistical package (SPSS Inc, Chicago) was used.
RESULTS
Eighty-seven patients were enrolled in the study. Nine were withdrawn: three due to epidural catheters becoming dislodged, two because of inadequate data recordings, one because the epidural was a failure and three because they refused to participate in the study on arriving in theatre. Eight withdrawals were from Group M and one from Group P. Data were collected for a total of 78 patients: 44 in Group P and 34 in Group M. Demographic data were similar for the two groups (Table 1) . Group P used 192 mg (SD 69.5 mg), 76.8 ml (SD 28 ml) over 24 hours. Group M used 38 ml (SD 42 ml) of normal saline over 24 hours.
One patient in Group M and one in Group P required a single dose of IM pethidine. Time-specific pain scores did differ significantly, being higher for Group M at two hours (P<0.001) and higher for Group P at 6, 8 and 24 hours (P<0.001) (Figure 1) .
Promethazine was given to 10 patients in Group M and four in Group P. Despite promethazine one patient in Group M considered the itch to be unbearable. Group P had lower itch scores at 2, 6 and 8 hours postoperatively (P<0.001). There was no significant difference in itch scores between the two groups at 24 hours (P=0.061) (Figure 2) .
Metoclopramide was given to seven patients in Group M and four in Group P. One patient in Group P had persistent nausea. Group P had lower nausea scores at two hours (P<0.002) and 8 hours (P=0.009), but there was no difference in nausea scores at 6 hours (P=0.339). Group M had lower nausea scores at 24 hours (P<0.001) (Figure 3 ).
DISCUSSION
Epidural morphine, although often providing good analgesia, may be associated with inadequate analgesia, itch, vomiting and respiratory depression 2, 14 . Morphine is a hydrophilic opioid that takes 20 to 30 minutes to cross the dura and reaches a maximum cerebrospinal fluid (CSF) concentration 60 to 90 minutes after epidural administration. Analgesia typically appears after 20 to 40 minutes and lasts up to 18 to 28 hours. The pharmacokinetic characteristics of morphine favour its suitability for singledose epidural use. Interestingly, however, morphine Values are mean (SD). has also been used successfully for PCEA, although its slow onset of action would probably be a disadvantage in comparison to pethidine 14 . Epidural pethidine, especially by PCEA, has been suggested as an alternative to morphine 15 . Epidural pethidine has intermediate lipophilicity and crosses the dura in five to eight minutes, reaching a peak CSF concentration in 15 to 30 minutes. The onset and duration of analgesia are dose dependent: 25 mg appears to be the optimal bolus dose, providing analgesia within 12 minutes, with a duration ranging from 40 minutes to 4 hours 7, 8 . These properties make epidural pethidine a good candidate for PCEA 7, 10, 16 . A potentially serious side-effect of epidural opioids is delayed respiratory depression. Less cephalad spread occurs with pethidine than with morphine 8 , explaining why delayed respiratory depression is rarer with pethidine than the 0.25% incidence with morphine 8, 17 . Pethidine has, however, been associated with early respiratory depression 7, 10 . The use of optimal concentrations and doses of epidural pethidine is important 7 . In two separate studies of epidural pethidine following caesarean section by Paech et al 4 and Rosaeg and Lindsay 6 , patients used 16 mg/h and 16.5 mg/h respectively. In the current study, epidural pethidine consumption was much lower at 8 mg/h. This is closer to that of the 5-6 mg/h found in a post-thoracotomy study by Etches et al 18. The difference in drug requirement may have occurred because the patients in our study received regular paracetamol and those in the study by Etches et al both indomethacin and epidural bupivacaine 0.125%. Patients in the other studies were not given these supplemental analgesics. Our study and that of Etches et al used pethidine solutions of 0.25% and 0.1% respectively, compared with Paech et al 0.4% and Rosaeg and Lindsay 1% solutions. The patients in the latter study also received a continuous infusion of epidural pethidine at 10 mg/h. These differences in methodology may account for the differences in dosage requirement and analgesic outcome. Ngan Kee suggests pethidine solutions no greater than 0.5% appear to be optimal 7 . Ngan Kee et al also suggested that the optimal dose of bolus pethidine is 25 mg in a 5 ml volume 8 . In the present study the higher pain score in Group M at two hours and lower pain scores in Group M at six, eight, and 24 hours are difficult to explain. These lower pain scores in Group M at six, eight, and 24 hours might be explained by superior analgesia from morphine, failure of patients with PCA devices to titrate to pain scores of zero, or because 15 mg boluses of pethidine were sub-optimal 7 . The largest difference in pain scores occurred at six and eight hours, a result similar to that in a study by Rosaeg and Lindsay, in which patients receiving epidural pethidine also had higher pain scores between 8 and 16 hours 6 . A larger study would be useful to elucidate any analgesic differences.
That study also suggested that PCEA pethidine resulted in a lower incidence of opioid-related sideeffects 6 . In our study the incidence of itch was significantly lower with pethidine at two, six, and eight hours, the lack of difference between groups at 24 hours being consistent with the fall in CSF morphine levels by this time. Group M had more nausea at two and eight hours, but this responded to treatment with metoclopramide and both groups had median nausea scores of zero at these times, suggesting that this effect is not clinically important.
Due to the intermediate lipophilicity of pethidine, the total dose requirements of epidural pethidine are about half those of intravenous PCA pethidine 4, 19, 20 . The 24 hour pethidine consumption of 192 mg (SD 69.5 mg) in the present study was less than one would expect from intravenous PCA pethidine after caesarean section. This systemic opioid-sparing effect of epidural administration is, however, much less with pethidine than morphine 4, [21] [22] [23] . In terms of reducing neonatal opioid exposure via breast milk, epidural morphine may be preferable 7 . In conclusion, pethidine PCEA resulted in less itch than a single 4 mg bolus of epidural morphine at two, six and eight hours postoperatively, but with no difference at 24 hours. Other outcome measures such as analgesia and the incidence of nausea did not differ consistently between the pethidine and morphine groups. As a result, it is a matter of individual clinical opinion whether the extra time, expense, equipment and higher systemic opioid levels associated with PCEA pethidine are worth the lower incidence of itch. In cases where patients have experienced significant problems with morphine-induced itch in the past, or have other contraindications to morphine, pethidine PCEA may be a good alternative for the provision of analgesia following caesarean section.
